Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgery Today

25-03-2024 | Colorectal Cancer | Original Article

Oncologic investigation of the interval from stent placement to surgery in patients with obstructive colorectal cancer

Authors: Shintaro Kanaka, Akihisa Matsuda, Takeshi Yamada, Yasuyuki Yokoyama, Satoshi Matsumoto, Goro Takahashi, Hiromichi Sonoda, Ryo Ohta, Kay Uehara, Seiichi Shinji, Takuma Iwai, Kohki Takeda, Kumiko Sekiguchi, Sho Kuriyama, Toshimitsu Miyasaka, Hiroshi Yoshida

Published in: Surgery Today

Login to get access

Abstract

Purpose

Self-expandable metallic stent (SEMS) placement is widely used as a bridge to surgery (BTS) procedure for obstructive colorectal cancer. However, evidence regarding the optimal interval between SEMS placement and elective surgery is lacking.

Methods

We retrospectively collected data from patients with BTS between January 2013 and October 2021. Inverse probability treatment-weighted propensity score analyses were used to compare short- and long-term outcomes between the short-interval (SI) and long-interval (LI) groups, using a cutoff of 20 days.

Results

In total, 138 patients were enrolled in this study (SI group, n = 63; LI group, n = 75). In the matched cohort, the patients’ backgrounds were well balanced. The incidence of Clavien–Dindo grade ≥ II postoperative complications was not significantly different between the SI and LI groups (19.0% vs. 14.0%, P = 0.47). There were no significant differences between the SI and LI groups in the 3-year recurrence-free survival (68.0% vs. 76.4%, P = 0.73) or 3-year overall survival rates (86.0% vs. 90.6%, P = 0.72).

Conclusions

A longer interval did not deteriorate the oncological outcomes. Individual perioperative management with an appropriate interval to improve the patient’s condition is required to ensure safe surgery.
Literature
1.
Carraro PGS, Segala M, Cesana BM, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a 10 year follow up after one stage curative surgery. Dis Colon Rectum. 2001;44:243–50.CrossRefPubMed
2.
De Salvo GL, Gava C, Pucciarelli M. Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? Cochrane Database Syst Rev. 2004;2015(2):CD002101.
3.
Manceau G, Voron T, Mege D, Bridoux V, Lakkis Z, Venara A, AFC (French Surgical Association) Working Group, et al. Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients. Langenbecks Arch Surg. 2019;404:717–29.CrossRefPubMed
4.
Saida Y, Sumiyama Y, Nagao J, Uramatsu M. Long-term prognosis of preoperative “bridge to surgery” expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum. 2003;46:S44–9.PubMed
5.
Amelung FJ, Draaisma A, Consten ECJ, Siersema PD, ter Borg F. Self-expandable metal stent placement versus emergency resection for malignant proximal colon obstructions. Surg Endosc. 2017;31:4532–41.CrossRefPubMed
6.
Dohmoto M, Rupp KD, Hohlbach G. Endoscopicallyimplanted prosthesis in rectal carcinoma. Dtsch Med Wochenschr. 1990;115:915.PubMed
7.
Yang SY, Park YY, Han YD, Cho MS, Hur H, Min BS, et al. Oncologic outcomes of self-expandable metallic stent as a bridge to surgery and safety and feasibility of minimally invasive surgery for acute malignant colonic obstruction. Ann Surg Oncol. 2019;26:2787–96.CrossRefPubMed
8.
Matsuda A, Miyashita M, Matsumoto S, Matsutani T, Sakurazawa N, Takahashi G, et al. Comparison of long-term outcomes of colonic stent as “bridge to surgery” and emergency surgery for malignant large-bowel obstruction: a meta-analysis. Ann Surg Oncol. 2015;22:497–504.CrossRefPubMed
9.
Erichsen R, Horváth-Puhó E, Jacobsen JB, Nilsson T, Baron JA, Sørensen HT. Long-term mortality and recurrence after colorectal cancer surgery with preoperative stenting: a Danish nationwide cohort study. Endoscopy. 2015;47(6):517–24.CrossRefPubMed
10.
Allievi N, Ceresoli M, Fugazzola P, Montori G, Coccolini F, Ansaloni L. Endoscopic stenting as bridge to surgery versus emergency resection for left-sided malignant colorectal obstruction: an updated meta-analysis. Int J Surg Oncol. 2017;2017:2863272.PubMedPubMedCentral
11.
Matsuda A, Yamada T, Ohta R, Sonoda H, Shinji S, Iwai T, et al. Surgical site infections in gastroenterological surgery. J Nippon Med Sch. 2023;90:2–10.CrossRefPubMed
12.
van Hooft JE, Veld JV, Arnold D, Beets-Tan RGH, Everett S, Götz M, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Update 2020. Endoscopy. 2020;52:389–407.CrossRefPubMed
13.
Lee GJ, Kim HJ, Baek JH, Lee WS, Kwon KA. Comparison of short-term outcomes after elective surgery following endoscopic stent insertion and emergency surgery for obstructive colorectal cancer. Int J Surg. 2013;11(6):442–6.CrossRefPubMed
14.
Gianotti L, Tamini N, Nespoli L, Rota M, Bolzonaro E, Frego R, et al. A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction. Surg Endosc. 2013;27:832–42.CrossRefPubMed
15.
Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Kawano Y, Yamada T, et al. Optimal interval from placement of a self-expandable metallic stent to surgery in patients with malignant large bowel obstruction: a preliminary study. Surg Laparosc Endosc Percutan Tech. 2018;28:239–44.CrossRefPubMed
16.
Veld JV, Kumcu A, Amelung FJ, Borstlap WAA, Consten ECJ, Dekker JWT, Dutch Snapshot Research Group, et al. Time interval between self-expandable metal stent placement or creation of a decompressing stoma and elective resection of left-sided obstructive colon cancer. Endoscopy. 2021;53:905–13.CrossRefPubMed
17.
Broholm M, Kobborg M, Frostberg E, Jeppesen M, Gögenür I. Delay of surgery after stent placement for resectable malignant colorectal obstruction is associated with higher risk of recurrence. Int J Colorectal Dis. 2017;32:513–6.CrossRefPubMed
18.
Kye BH, Kim JH, Kim HJ, Lee YS, Lee IK, Kang WK, et al. The optimal time interval between the placement of self-expandable metallic stent and elective surgery in patients with obstructive colon cancer. Sci Rep. 2020;10:9502.CrossRefPubMedPubMedCentral
19.
Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, et al. A longer interval after stenting compromises the short- and long-term outcomes after curative surgery for obstructive colorectal cancer. Surg Today. 2022;52:681–9.CrossRefPubMed
20.
Saito S, Yoshida S, Isayama H, Matsuzawa T, Kuwai T, Maetani I, et al. A prospective multicenter study on self-expandable metallic stents as a bridge to surgery for malignant colorectal obstruction in Japan: efficacy and safety in 312 patients. Surg Endosc. 2016;30:3976–86.CrossRefPubMed
21.
Suzuki M, Okada K, Koyama N, Yamashita N, Yamagishi A, Yamada T, et al. Usefulness of a colonic stent for colonic obstruction caused by lung cancer metastasis. J Nippon Med Sch. 2021;88:556–60.CrossRefPubMed
22.
Hashiguchi Y, Muro K, Saito Y, Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.CrossRefPubMed
23.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.CrossRefPubMed
24.
Dindo D. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
25.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
26.
Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661–79.CrossRefPubMedPubMedCentral
27.
Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75:45–9.CrossRefPubMed
28.
Cwikiel W, Andrén-Sandberg A. Malignant stricture with colovesical fistula: stent insertion in the colon. Radiology. 1993;186:563–4.CrossRefPubMed
29.
Cirocchi R, Farinella E, Trastulli S, Desiderio J, Listorti C, Boselli C, et al. Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. Surg Oncol. 2013;22:14–21.CrossRefPubMed
30.
Takahashi G, Yamada T, Iwai T, Takeda K, Koizumi M, Shinji S, et al. Oncological assessment of stent placement for obstructive colorectal cancer from circulating cell-free DNA and circulating tumor DNA dynamics. Ann Surg Oncol. 2018;25:737–44.CrossRefPubMed
31.
32.
Ho MF, Futaba K, Chu S, Hon SSF, Ng SSM. Delaying surgery for optimization after colonic stent bridging is safe for left-sided malignant large bowel obstruction: result from 10-year experience and risks factor analysis. Surg Oncol. 2023;47: 101918.CrossRefPubMed
33.
de Roos MAJ, Hugen N, Hazebroek EJ, Bilgen EJS. Delayed surgical resection of primary left-sided obstructing colon cancer is associated with improved short- and long-term outcomes. J Surg Oncol. 2021;124:1146–53.CrossRefPubMed
34.
Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261:497–505.CrossRefPubMed
35.
Law WL, Choi HK, Lee YM, Ho JW. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol. 2007;14:2559–66.CrossRefPubMed
36.
Alonso S, Pascual M, Salvans S, Mayol X, Mojal S, Gil MJ, et al. Postoperative intra-abdominal infection and colorectal cancer recurrence: a prospective matched cohort study of inflammatory and angiogenic responses as mechanisms involved in this association. Eur J Surg Oncol. 2015;41:208–14.CrossRefPubMed
37.
Salvans S, Mayol X, Alonso S, Messeguer R, Pascual M, Mojal S, et al. Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: an insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Ann Surg. 2014;260:939–43; discussion 943–4.
38.
Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP, et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum. 2013;56:1339–48.CrossRefPubMed
39.
Matsuda A, Yamada T, Takahashi G, Matsumoto S, Yokoyama Y, Sonoda H, et al. Postoperative infectious complications have a negative oncological impact in patients after stent placement with malignant large bowel obstruction. Int J Colorectal Dis. 2023;38:2.CrossRefPubMed
40.
Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle. 2018;9:53–9.CrossRefPubMed
41.
Kanazawa Y, Yamada T, Kakinuma D, Matsuno K, Ando F, Fujita I, et al. Skeletal muscle mass depletion after gastrectomy negatively affects the prognosis of patients with gastric cancer. Anticancer Res. 2020;40:4271–9.CrossRefPubMed
42.
Sonoda H, Yamada T, Matsuda A, Yokoyama Y, Ohta R, Shinji S, et al. The T-CEA score: a useful prognostic indicator based on postoperative CEA and pathological T4 levels for patients with stage II-III colorectal cancer. Surg Today. 2023;53:890–8.CrossRefPubMed
43.
Han JG, Wang ZJ, Zeng WG, Wang YB, Wei GH, Zhai ZW, et al. Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer. BMC Cancer. 2020;20:57.CrossRefPubMedPubMedCentral
Metadata
Title
Oncologic investigation of the interval from stent placement to surgery in patients with obstructive colorectal cancer
Authors
Shintaro Kanaka
Akihisa Matsuda
Takeshi Yamada
Yasuyuki Yokoyama
Satoshi Matsumoto
Goro Takahashi
Hiromichi Sonoda
Ryo Ohta
Kay Uehara
Seiichi Shinji
Takuma Iwai
Kohki Takeda
Kumiko Sekiguchi
Sho Kuriyama
Toshimitsu Miyasaka
Hiroshi Yoshida
Publication date
25-03-2024
Publisher
Springer Nature Singapore
Published in
Surgery Today
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-024-02818-w